Logo image of PAFO

PACIFICO ACQUISTION CORP (PAFO) Stock Fundamental Analysis

NASDAQ:PAFO - Nasdaq - US69512X1037 - Common Stock - Currency: USD

4.2  -3.7 (-46.84%)

After market: 6.05 +1.85 (+44.05%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PAFO. PAFO was compared to 0 industry peers in the Unkown industry. The financial health of PAFO is average, but there are quite some concerns on its profitability. PAFO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PAFO had negative earnings in the past year.
PAFO had a negative operating cash flow in the past year.
PAFO Yearly Net Income VS EBIT VS OCF VS FCFPAFO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 -100K -200K -300K

1.2 Ratios

PAFO has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAFO Yearly ROA, ROE, ROICPAFO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 -0.1 -0.2 -0.3

1.3 Margins

PAFO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAFO Yearly Profit, Operating, Gross MarginsPAFO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021

More info and screens

6

2. Health

2.1 Basic Checks

PAFO Yearly Shares OutstandingPAFO Yearly Shares OutstandingYearly Shares Outstanding 2021 2M 4M 6M
PAFO Yearly Total Debt VS Total AssetsPAFO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 10M 20M 30M 40M 50M

2.2 Solvency

PAFO has an Altman-Z score of 6.45. This indicates that PAFO is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for PAFO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.45
ROIC/WACCN/A
WACCN/A
PAFO Yearly LT Debt VS Equity VS FCFPAFO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 0 10M 20M 30M 40M 50M

2.3 Liquidity

PAFO has a Current Ratio of 17.03. This indicates that PAFO is financially healthy and has no problem in meeting its short term obligations.
PAFO has a Quick Ratio of 17.03. This indicates that PAFO is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 17.03
Quick Ratio 17.03
PAFO Yearly Current Assets VS Current LiabilitesPAFO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAFO Yearly Revenue VS EstimatesPAFO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021
PAFO Yearly EPS VS EstimatesPAFO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAFO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAFO Price Earnings VS Forward Price EarningsPAFO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAFO Per share dataPAFO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PAFO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PACIFICO ACQUISTION CORP

NASDAQ:PAFO (12/16/2022, 8:18:34 PM)

After market: 6.05 +1.85 (+44.05%)

4.2

-3.7 (-46.84%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.23%
Inst Owner Change0%
Ins Owners0.47%
Ins Owner Change0%
Market Cap31.48M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS7.41
TBVpS7.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.03
Quick Ratio 17.03
Altman-Z 6.45
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A